genOway Stock OTC Markets

GWYNF

FR0004053510

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

03-30	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-31	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Analysts' recommendations: genOway

22/11/23	GenOway: sharp rise, broker initiates buy recommendation
22/11/23	GenOway: Euroland initiates buy coverage

More recommendations

News in other languages: genOway

06-03	GenOway : 20260626 Avis de convocation
06-03	GenOway : 20260626 Demande d’envoi de documents et de renseignements
05-05	GenOway : 20260505 Rapport de gestion du conseil d’administration
04-14	GenOway poursuit son développement international : lancement d’un modèle de « Franchises genOway » avec l’ouverture des deux premières au Canada et en Australie
04-14	Genoway : Poursuite du développement international : lancement d’un modèle de " Franchises genOway " avec l’ouverture des deux premières au Canada et en Australie

More news

Managers and Directors: genOway

Manager	Title	Age	Since
Christian Grenier CEO	Chief Executive Officer	-	-
Alexandre Fraichard COO	Chief Operating Officer	-	01/03/1999
Benjamin Bruneau DFI	Director of Finance/CFO	-	01/10/2015

Director	Title	Age	Since
Alexandre Fraichard BRD	Director/Board Member	-	01/03/1999
Christian Grenier CHM	Chairman	-	-
Laurent Fraisse BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GENOWAY	-.--%	-.--%	-	-	25.62M
LONZA GROUP AG	+0.96%	+1.94%	-12.97%	-13.01%	43.03B
REVOLUTION MEDICINES, INC.	+4.02%	+7.26%	+294.33%	+533.90%	32.71B
IQVIA HOLDINGS INC.	-1.69%	-2.76%	+13.70%	-16.14%	30.29B
BEONE MEDICINES AG	+1.41%	-0.70%	-0.53%	+28.87%	29.4B
CELLTRION, INC.	+1.16%	+2.10%	+14.27%	+22.05%	25.08B
ASCENDIS PHARMA A/S	+2.40%	+6.10%	-	-	13.54B
MEDPACE HOLDINGS, INC.	+0.03%	+2.92%	+56.75%	+114.15%	13.35B
EUROFINS SCIENTIFIC SE	-1.09%	-2.37%	+5.07%	+5.25%	12.97B
IONIS PHARMACEUTICALS, INC.	+0.93%	-0.70%	+107.81%	+81.19%	12.11B
Average	+0.81%	+0.83%	+59.80%	+94.53%	23.61B
Weighted average by Cap.	+1.05%	+0.82%	+60.10%	+102.52%

See all sector performances

genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).

Employees

Sector

Biotechnology & Medical Research

More about the company

Income Statement and Estimates

More financial data

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

Market Cap	24.99M 28.96M 23M 21.59M 40.5M 2.74B 40.94M 272M 106M 1.34B 109M 106M 4.64B	P/E Ratio 2023 *	-	P/E Ratio 2024	-
Enterprise Value	25.61M 29.68M 23.58M 22.13M 41.51M 2.81B 41.96M 279M 109M 1.37B 111M 109M 4.76B	EV / Sales 2023	1.64x	EV / Sales 2024	1.28x
Free-Float	79.77%	Yield 2023 *	-	Yield 2024	-

03-30	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-31	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI
12-16	GenOway Société anonyme agreed to acquire Data Science and AI assets in OMICS platform for ?7 million.	CI
11-19	GenOway Soars 18% on Strong Momentum from Chinese Joint Venture
24/09/25	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
27/03/25	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/09/24	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
19/07/24	GenOway: 15% growth in first-half sales
22/11/23	GenOway: sharp rise, broker initiates buy recommendation
22/11/23	GenOway: Euroland initiates buy coverage
17/10/23	GenOway: creation of a joint venture in Shanghai
22/09/23	GenOway: profitability target achieved ahead of schedule
21/09/23	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

03-16	GenOway : 20250627 Avis de convocation	PU
11-18	Accélération du développement en Chine : la coentreprise genOway Shanghai devient un moteur clé de croissance pour le Groupe	PU
22/09/25	GenOway : Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%	PU
27/03/24	GenOway : Résultats annuels 2023	PU
22/09/23	GenOway : Résultats du 1er semestre 2023	PU

	2023	2024
Net sales	26.51M 30.72M 24.41M 22.9M 42.98M 2.91B 43.44M 289M 113M 1.42B 115M 113M 4.93B	27.53M 31.91M 25.35M 23.79M 44.63M 3.02B 45.11M 300M 117M 1.48B 120M 117M 5.12B
Net income	1.57M 1.82M 1.44M 1.35M 2.54M 172M 2.57M 17.08M 6.66M 84.08M 6.81M 6.67M 291M	1.83M 2.12M 1.69M 1.58M 2.97M 201M 3M 19.95M 7.78M 98.2M 7.96M 7.79M 340M
Net Debt	2.97M 3.45M 2.74M 2.57M 4.82M 326M 4.87M 32.39M 12.63M 159M 12.92M 12.65M 552M	623K 722K 574K 538K 1.01M 68.4M 1.02M 6.79M 2.65M 33.42M 2.71M 2.65M 116M

genOway Stock OTC Markets

Stocks

GWYNF

FR0004053510

Biotechnology & Medical Research

Valuation: genOway

Latest news : genOway

Analysts' recommendations: genOway

Press Releases: genOway

News in other languages: genOway

Managers and Directors: genOway

Other Biotechnology & Medical Research

Financials

Company Profile

Income Statement and Estimates